Corrigendum to: Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases

Affiliations

¹ Global Health, GSK, Brentford, UK.
² Corporate Responsibility, Merck & Co., Inc., Kenilworth, NJ, USA.
³ Bridges to Development, Seattle, Washington, USA.
⁴ International Federation of Pharmaceutical Manufacturers and Associations, Geneva, Switzerland.
⁵ Adrian Hopkins Consulting, Gravesend, Kent, UK.
⁶ Global Health & Patient Access, Pfizer, Inc. New York, NY, USA.
⁷ Johnson & Johnson Global Public Health, New Brunswick, NJ, USA.
⁸ Global Health, Group Corporate Affairs Merck KGaA, Darmstadt, Germany.
⁹ Global Health Programs, Sanofi, Paris, France.
¹⁰ Global Patient Solutions Africa, Gilead Sciences, Foster City, CA, USA.
¹¹ Neglected Tropical Disease Programs, Bayer AG Pharmaceuticals, Berlin, Germany.
¹² Sustainability, Eisai Co. Ltd, Tokyo, Japan.
¹³ Novartis Global Health & Corporate Responsibility, Basel, Switzerland.
¹⁴ Department of Control of Neglected Tropical Diseases, WHO Geneva, Geneva, Switzerland.
¹⁵ Department of Communicable Diseases WHO Regional Office for South-East Asia, Delhi, India.
¹⁶ Expanded Special Project for Elimination of NTDs (ESPEN) WHO Regional Office for Africa, Brazzaville, Congo.
¹⁷ Division of Programs for Disease Control WHO Regional Office for the Western Pacific, Manila, Philippines.
¹⁸ NTD Support Centre, Task Force for Global Health Atlanta, USA.

Published Erratum

Mark Bradley et al. Trans R Soc Trop Med Hyg. 2021.

. 2021 May 8;115(5):575.

doi: 10.1093/trstmh/trab046.

¹ Global Health, GSK, Brentford, UK.
² Corporate Responsibility, Merck & Co., Inc., Kenilworth, NJ, USA.
³ Bridges to Development, Seattle, Washington, USA.
⁴ International Federation of Pharmaceutical Manufacturers and Associations, Geneva, Switzerland.
⁵ Adrian Hopkins Consulting, Gravesend, Kent, UK.
⁶ Global Health & Patient Access, Pfizer, Inc. New York, NY, USA.
⁷ Johnson & Johnson Global Public Health, New Brunswick, NJ, USA.
⁸ Global Health, Group Corporate Affairs Merck KGaA, Darmstadt, Germany.
⁹ Global Health Programs, Sanofi, Paris, France.
¹⁰ Global Patient Solutions Africa, Gilead Sciences, Foster City, CA, USA.
¹¹ Neglected Tropical Disease Programs, Bayer AG Pharmaceuticals, Berlin, Germany.
¹² Sustainability, Eisai Co. Ltd, Tokyo, Japan.
¹³ Novartis Global Health & Corporate Responsibility, Basel, Switzerland.
¹⁴ Department of Control of Neglected Tropical Diseases, WHO Geneva, Geneva, Switzerland.
¹⁵ Department of Communicable Diseases WHO Regional Office for South-East Asia, Delhi, India.
¹⁶ Expanded Special Project for Elimination of NTDs (ESPEN) WHO Regional Office for Africa, Brazzaville, Congo.
¹⁷ Division of Programs for Disease Control WHO Regional Office for the Western Pacific, Manila, Philippines.
¹⁸ NTD Support Centre, Task Force for Global Health Atlanta, USA.

No abstract available

Erratum for

Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases.
Bradley M, Taylor R, Jacobson J, Guex M, Hopkins A, Jensen J, Leonard L, Waltz J, Kuykens L, Sow PS, Madeja UD, Hida T, Ole-Moiyoi K, King J, Argaw D, Mohamed J, Polo MR, Yajima A, Ottesen E. Bradley M, et al. Trans R Soc Trop Med Hyg. 2021 Jan 28;115(2):136-144. doi: 10.1093/trstmh/traa167. Trans R Soc Trop Med Hyg. 2021. PMID: 33452881 Free PMC article.